Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ARTL
#9739
Artelo Biosciences, Inc. Common Stock
3.760
0
USD
-3.59%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
-3.59%
Monatliche Änderung
+213.33%
6 month change
+213.33%
Jahresänderung
+213.33%
Vorheriger Schlusskurs
3.900
0
Open
3.760
0
Bid
3.760
0
Ask
3.763
0
Low
3.760
0
High
3.760
0
Volumen
1
Märkte
Aktien
Gesundheitswesen
ARTL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
537.95 K
546.84 K
546.84 K
1.32 M
2.02 M
2.12 M
—
Valuation ratios
Enterprise value
—
—
—
17.29 M
7.3 M
1.99 M
—
Price to earnings ratio
—
—
—
-0.7
-0.22
-0.1
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
1.32
0.35
0.15
—
Price to book ratio
—
—
—
0.64
0.47
0.99
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.8
0.67
0.74
0.73
1.49
3.63
Return on equity %
0.18
1.32
3.64
2.29
4.93
3.28
14.13
Return on invested capital %
115.86
357.6
366.21
464.69
384.5
340.43
1 555.83
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.15
1.44
0.49
0.39
0.38
0.17
1.43
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.18
0.21
0.16
—
Long term debt to total equity ratio
—
—
—
0.56
1.38
0.34
—
Per share metrics
Operating cash flow per share
1.45
4.78
2.92
0.9
4.44
2.83
11.09
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.39
0.47
1.74
0.44
2.5
0.58
5.26
Net current asset value per share
9.27
4.76
2.53
3.89
2.32
0.68
9.41
Tangible book value per share
8.03
1.52
-2.54
-1.1
-1.79
-0.75
-6.17
Working capital per share
7.97
1.46
-2.6
-6.06
-3.85
-3.25
-15.77
Book value per share
11.82
5.32
1.19
2.45
0.8
1.24
5.68
Nachrichten
Artelo Biosciences führt Aktienzusammenlegung im Verhältnis 3 zu 1 durch
Artelo Biosciences implements 3-for-1 reverse stock split
Artelo Biosciences: Jahresverlust steigt auf 12,9 Mio. US-Dollar
Artelo Biosciences reports $12.9M loss for 2025
Fehlendes Quorum: Artelo Biosciences vertagt Jahreshauptversammlung
Artelo Biosciences adjourns annual meeting due to lack of quorum
White House launches Medicare pilot program for CBD reimbursement
Artelo: FABP5-Hemmer zeigt Potenzial bei Angstzuständen und Depressionen
Artelo’s FABP5 inhibitor shows promise for anxiety and depression
Artelo Biosciences beruft Mark Spring zum neuen Finanzvorstand
Artelo Biosciences appoints Mark Spring as new CFO
Artelo Biosciences ernennt Mark Spring zum CFO und passt Managerverträge an